VOLUME-REDUCING LIQUID ARRAYER AND ASSOCIATED METHODS
FIELD OF THE INVENTION The present invention relates to a liquid delivery apparatus and, more particularly, to a volume-reducing liquid arrayer apparatus for delivering a liquid solution from a reservoir to a substrate in the form of an array of portions of the liquid solution and associated methods of use and fabrication.
BACKGROUND OF THE INVENTION Large scale, multiple sample, parallel biochemistry assays, automated instruments, and system integration (instrument, databases and analytical tools) using the latest bioinformatics technologies are key factors for advancing the field of functional genomics. In recent years, DNA chip technology has been a focal point of genomic scientists and potential customers of genomics technology because of the ability of the DNA chip to assay a large number of genes in parallel. DNA chip technology can be used, for example, in gene expression assaying (parallel Northern blotting) to determine gene functions, in polymorphism detection and molecular marker genotyping (for example, SNP), to provide efficient genetic mapping, and, most importantly, in human disease diagnostics and in phenotype prediction for genetic manipulation of plants and animals. Further, the integration of DNA chip and two-dimensional protein data analyses is an important step in correlating the results of genomic and protemic studies.
Currently, on-chip synthesis and robotic dispensing are two methods used to prepare biosamples on DNA biochips which are used to conduct multiple sample parallel bioassays. On-chip synthesis is disclosed, for example, in U.S. Patent Nos. 5,800,992 and 5,744,305 to Fodor et al. which describe an oligonucleotide-based chip (herein called the "Fodor chip") generally utilizing a flat silicon surface for in situ synthesis of the oligonucleotides on the chip surface using combinatory chemistry. The probe arrays are manufactured using a light-directed chemical synthesis process which combines solid-phase chemical synthesis with photolithographic fabrication techniques. A series of photolithographic masks are used to define chip exposure sites before specific chemical synthesis steps are performed to produce the desired
probes. This process constructs high-density arrays of oligonucleotides (probes) with each probe disposed in a predetermined position in the array. Typically, multiple probe arrays are simultaneously synthesized on a large silicon wafer before the wafer is diced and the individual probe arrays are packaged in cartridges for subsequent use in bioassays.
However, the Fodor chip is typically limited to short oligonucleotide lengths, where the oligos have a small number (ie: 25) of nucleotide bases. The Fodor chip, therefore, may also be limited by experimental error associated with on-chip oligonucleotide synthesis and with short oligonucleotide hybridization error, which is generally associated with non-specific hybridization in a relaxed condition. Thus, due to these inherent experimental errors, techniques utilizing the Fodor chip may be prone to poor experimental repeatability. In addition, the Fodor chip may further be limited by slow hybridization rates due to the small effective hybridization area and random probe solution flow on the chip surface. In some instances, RNA amplification may also be required to increase the RNA concentration in the probe solution, which may make the Fodor chip unsuitable for certain applications, for example, monitoring gene expression. Thus, procedures involving the Fodor chip may be cost inefficient due to the complexities and limitations involved in producing the chip (labor intensive and time consuming procedures which add to the cost of the chip), capturing the necessary images, and analyzing the collected data.
Robotic dispensing of biosamples in the preparation of biochips is disclosed, for example, in U.S. Patent No. 5,807,522 to Brown et al. which describes a cDNA- based microarray chip (herein called the "Brown chip") that utilizes cDNA samples disposed in a microarray on the surface of a chip comprising a glass slide. The cDNA segments are typically chosen from cDNA libraries of EST sequencing projects. Each cDNA segment may range in length from several hundred to several thousand nucleotides. The nucleotide sequences in the cDNA segments are generally known, though cDNA segments without nucleotide sequence information and synthetic oligos may also be used in fabricating a Brown chip. The cDNA samples are usually delivered onto the chip using a robot having a three-dimensional motion control system and the ability to concurrently deposit multiple samples on the chip using a plurality of spotting pins. The spotting pins are typically dipped into DNA solutions before being moved to predetermined x-y positions over a glass slide. The pins are
then brought into contact with the surface of the glass slide such that the biosamples are deposited on the slide. The pins must then be washed and dried before being used for further biosample deposition.
However, the Brown chip is limited, for example, in that the robotic system used to deliver the biosamples to the chip can only do so for a portion of a chip (4 to 16 spots) at a time thus contributing to a time-intensive fabrication process. In addition, error in the x-y positioning of the spotting pins by the robot at each successive portion on the chip may contribute to poor accuracy of experimental results. Further, varying amounts of the cDNA samples and other inconsistencies in the biosamples deposited by the spotting pins may contribute to a lack of uniformity in the DNA samples deposited on a single chip and between successive chips. Also, the robotic system necessary to perform the precise and demanding task of biochip fabrication may be very complex and expensive. Robotic systems using spotting pins for delivering the biosamples to the chip further typically require that the DNA solutions be prepared separately before the biosamples are delivered to the chip.
Thus, the extra handling necessary for delivering the biosamples from the solution to the chip contributes to inconsistencies in the deposited samples and increases the possibility of sample contamination.
Thus, though the Fodor and Brown DNA chips are useful for some small-scale research in functional genomics, they are not suitable for future practical large-scale applications primarily due to high cost, time intensive fabrication of the DNA chip, and poor accuracy of experimental results. The poor accuracy of a surface-based biosample assay apparatus and method typically results from the low concentration of the complementary strands of DNA (or RNA) in the probe solution and the small effective hybridization area of the spots on surface-based chips. Further, surface- based chips, such as the Brown chip, are often prepared using a robot for transferring biosamples from a mass solution to individual spots on a glass substrate to form the microarray. The biosample transfer may be accomplished, for example, by a robot operating at an overall rate of about four dots per second. Since a microarray may include multiple thousands of individual samples, a surface-based microarray may be prone to lengthy formation times as well as possible sample contamination due to the robotic system.
Thus, there exists a need for a DNA chip preparation apparatus and associated method that is cost-effective and capable of fabricating biochips at a higher rate than current techniques. Preferably, the apparatus and method should be capable of producing more accurate biochips and more repeatable experimental results than is currently available with prior art DNA chips.
SUMMARY OF THE INVENTION The above and other needs are met by the present invention which, in one embodiment, provides a volume-reducing arrayer apparatus adapted to deliver a predetermined amount of a liquid solution from a reservoir to a substrate. The arrayer apparatus generally comprises at least one plate disposed between the reservoir and the substrate and a flow control device disposed between the at least one plate and the substrate and in communication with the at least one plate. The at least one plate is in communication with the reservoir and defines at least one plate capillary extending toward the substrate. The at least one plate capillary is configured to have a reduced volume with respect to the reservoir so as to receive a portion of the solution therefrom. The flow control device is in communication with the at least one plate and defines at least one flow control capillary corresponding to the at least one plate capillary and extending toward the substrate. The at least one flow control capillary is configured to have a reduced volume with respect to the at least one plate capillary. The flow control device is further configured to control the flow of a predetermined amount of the solution through the at least one flow control capillary, from the at least one plate capillary to the substrate.
Another advantageous embodiment of the present invention provides a volume-reducing arrayer apparatus adapted to deliver a predetermined amount of a liquid solution to a substrate. The arrayer apparatus comprises a reservoir for containing the solution, at least one arrayer block disposed between the reservoir and the substrate, a flow control device disposed between the at least one arrayer block and the substrate, and a stamper head disposed between the flow control device and the substrate. The at least one arrayer block is in communication with the reservoir and defines at least one arrayer capillary extending toward the substrate, wherein the at least one arrayer capillary is configured to have a reduced volume with respect to the reservoir so as to receive a portion of the solution therefrom. The flow control
device is in communication with the at least one arrayer block and defines at least one flow control capillary corresponding to the at least one arrayer capillary and extending toward the substrate. The at least one flow control capillary is also configured to have a reduced volume with respect to the at least one plate capillary. The flow control device is further configured to control the flow of a predetermined amount of the solution through the at least one flow control capillary. The stamper head is in communication with the flow control device and also defines at least one stamper capillary corresponding to the at least one flow control capillary and extending toward the substrate. The at least one stamper capillary is configured to have the predetermined amount of the solution channeled therethrough by the flow control device, from the at least one flow control capillary to the substrate.
A further advantageous aspect of the present invention comprises a method of fabricating a volume-reducing arrayer apparatus adapted to deliver a predetermined amount of a liquid solution from a reservoir to a substrate. First, a first plate defining at least one first plate capillary is operably engaged with a second plate defining at least one second plate capillary so as to form a continuous passage between each first plate capillary and the corresponding second plate capillary. A flow control device is then operably engaged with each of the second plate capillaries, wherein the flow control device is configured to control the flow of the solution through each second plate capillary, from each first plate capillary to the substrate. The at least one first plate capillary is in communication with the reservoir and has a reduced volume with respect thereto so as to receive a portion of the solution therein. The at least one second plate capillary corresponds to the at least one first plate capillary and has a reduced volume with respect thereto. Still a further advantageous aspect of the present invention comprises a method of delivering a biosample solution to a biochip. First, portions of the biosample solution are delivered from a microtiter plate containing the biosample solution to a plurality of first plate capillaries defined by a first plate, wherein the first plate capillaries are arranged in an array and each of the first plate capillaries has a predetermined diameter. At least a portion of the biosample solution from each of the first plate capillaries is then delivered to a corresponding second plate capillary in a plurality of second plate capillaries defined by a second plate. The second plate capillaries are arranged in an array corresponding to the first plate capillary array.
Further, each of the second plate capillaries has a diameter smaller than the first plate capillary diameter such that the smaller diameter of the second plate capillary provides a reduced volume per unit length of the solution therein with respect to the first plate capillary. At least a portion of the biosample solution from each of the second plate capillaries is then delivered to a substrate to form an array of samples on the substrate.
Thus, embodiments of a volume-reducing arrayer apparatus according to the present invention provide a non-robotic device for delivering biosamples onto biochips. An arrayer apparatus according to the present invention is capable of simultaneously depositing a large number of biosamples onto a number of biochips at a relatively high rate compared to current robotic devices. An arrayer apparatus according to the present invention further provides a relatively low cost and simple apparatus compared to current robotic systems. Since no movement is involved between the arrayer apparatus and the biochip during the delivery of the biosamples to the biochip, the biosamples are deposited on the chip with higher precision and greater uniformity while eliminating handling steps which tend to introduce experimental error. Further, the configuration of an arrayer apparatus according to the present invention facilitates integration of the arrayer apparatus and dispensing system with the DNA solution preparation measures, thus allowing the biosamples to be prepared immediately with the arrayer apparatus and immediately before delivery onto the biochip, thereby further eliminating handling steps in delivering the biosamples from the bulk solution to the biochip. Accordingly, a biochip preparation apparatus and associated method according to the present invention is capable of cost effectively manufacturing biochips at a higher rate than current techniques and results in more accurate biochips with higher repeatability of experimental results than current DNA chips. It will be recognized, therefore, that the present invention facilitates the achievement of these and other distinct advantages over prior art biochip fabrication devices and methods.
BRIEF DESCRIPTION OF THE DRAWINGS
Some of the advantages of the present invention having been stated, others will appear as the description proceeds, when considered in conjunction with the accompanying drawings, which are not necessarily drawn to scale, in which:
FIG. 1 is a perspective view of a volume-reducing arrayer for depositing a predetermined amount of a liquid on a substrate according to one embodiment of the present invention.
FIG. 2 is a side elevation of a volume-reducing arrayer for depositing a predetermined amount of a liquid on a substrate according to an alternate embodiment of the present invention.
FIG. 3A is a schematic of a volume-reducing liquid arrayer for depositing a predetermined amount of a liquid on a substrate according to one embodiment of the present invention. FIG. 3B shows top and bottom views of each plate comprising a volume- reducing arrayer according to the embodiment of the present invention shown in FIG. 3A.
FIG. 4A is a schematic of a volume-reducing arrayer for depositing a predetermined amount of a liquid on a substrate according to an alternate embodiment of the present invention.
FIG. 4B shows top and bottom views of the plates comprising a volume- reducing arrayer according to the embodiment of the present invention shown in FIG. 4A.
FIGS. 5A-5C are schematic representations of volume-reducing pathways in an arrayer according to embodiments of the present invention.
FIG. 6 is a schematic representation of a pumping device utilized in a pumping array comprising a portion of a volume-reducing liquid arrayer according to embodiments of the present invention.
FIG. 7 is a flowchart of a method of fabricating a volume-reducing liquid arrayer according to one embodiment of the present invention.
FIG. 8 is a flowchart of a method of delivering an array of biosample solutions to a biochip according to one embodiment of the present invention.
DETAILED DESCRIPTION OF THE INVENTION The present invention now will be described more fully hereinafter with reference to the accompanying drawings, in which preferred embodiments of the invention are shown. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein;
rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. Like numbers refer to like elements throughout.
FIGS. 1 and 2 disclose embodiments of a volume-reducing arrayer apparatus adapted to deliver a predetermined amount of a liquid solution to a substrate, the arrayer apparatus (also referred to herein as an "arrayer") being indicated generally by the numeral 110 and including the features of the present invention. The arrayer 110 generally comprises a reservoir 120, at least one arrayer block 140, a flow control device 160, and a stamper head 180 cooperating to deliver biosamples in the form of a liquid to a biochip 200.
In one advantageous embodiment of the present invention, the reservoir 120 comprises, for example, a microtiter plate constructed so as to store bulk DNA solutions therein. More particularly, for example, a 20cm x 20cm microtiter plate may contain a plurality of wells 122 arranged in an array, where each well 122 is capable of holding 5 to 200 microhters of a DNA solution. Thus, according to current technology, such a microtiter plate may, for example, hold as many as 10,000 DNA samples therein and may theoretically be used to fabricate approximately 5,000 to 10,000 separate biochips 200.
Underlying the reservoir 120, according to one advantageous embodiment, is at least one arrayer block 140, in the form of a plate, defining at least one and, in some instances, a plurality of arrayer capillaries 142. The arrayer capillaries 142 may be arranged in an array corresponding to the array of wells 122 in the reservoir 120. The wells 122 in the reservoir 120 may each have a valve (not shown) for controlling the flow of the liquid solution, and thus the biosamples, from the wells 122 into the corresponding arrayer capillaries 142 in the arrayer block 140. It is understood, however, that delivery of the solution from the wells 122 to the arrayer capillaries 142 may be accomplished by other delivery methods, wherein the reservoir 120 is in communication with, but not necessarily disposed atop, the arrayer block 140, consistent with the spirit and scope of the present invention. A typical biochip 200 is on the order of, for example, about one square centimeter to about four square centimeters and requires microscopically-sized samples to form the necessary oligonucleotide probes on the biochip 200. Thus, the liquid solution (also referred to herein as the "biosamples') released from the wells
122 must be reduced with respect to both the volume of the individual biosample as well as the area occupied by the well array 122.
The arrayer block 140 is thus configured to receive and reduce the volume of the biosamples from the reservoir 120 and to reduce the area occupied by the well array 122. As shown in FIGS. 3 A and 4 A, the arrayer block 140 is typically a flat plate having an upper surface 144 and a lower surface 145 and is sealed and adhered to the reservoir 120 by a thin film of silicon. The arrayer capillaries 142 defined by the arrayer block 140 are arranged in an array corresponding to the well array 122 in the reservoir 120 and each arrayer capillary 142 may extend, in some instances, from the upper surface 144 to the lower surface 145 of the arrayer block 140. At the lower surface 144 of the arrayer block 140, an array of indentations 146 is formed, wherein the indentation array 146 corresponds to at least a portion of the arrayer capillary array 142. In order to reduce the area occupied by the arrayer capillary array 142, the indentation array 146 is typically formed, for instance, toward the center of the arrayer block 140 and inwardly of at least some of the arrayer capillaries 142, though a variety of different configuration may be used in accordance with the spirit and scope of the present invention. A plurality of channels 148 are also formed in the lower surface 145 of the arrayer block 140, with each channel 148 extending between an arrayer capillary 142 and a corresponding indentation in the indentation array 146. As shown in FIGS. 3A, 3B, and 5A, the reduction in the arrayer capillary array 142 area may be accomplished with a single arrayer block 140, wherein the entire arrayer capillary array 142 is reduced in area to the size of the indentation array 146 by the single arrayer block 140.
As shown in FIGS. 4A, 4B, and 5B, reducing the arrayer capillary array 142 area may be alternatively accomplished with multiple arrayer blocks, wherein a first arrayer block 140 and a second arrayer block 150 are shown in this embodiment, and wherein each successive arrayer block reduces the area occupied by a particular subset of the first arrayer capillary array 142. For example, the second arrayer block 150 may be disposed below the first arrayer block 140 such that the lower surface 145 of the first arrayer block 140 is sealed by the upper surface 154 of the second arrayer block 150. The upper surface 154 of the second arrayer block 150 seals the first arrayer capillaries 142 in the first arrayer block 140 having channels 148 connected thereto, such that each first arrayer capillary 142 having a connected channel 148, and
that corresponding channel 148, are sealed. Accordingly, any portion of the solution flowing through the first arrayer capillary 142 flows through the channel 148 to the corresponding indentation 146.
The second arrayer block 150 further defines a plurality of second arrayer capillaries 151 therein corresponding to the array of indentations 146 in the first arrayer block 140. The second arrayer capillaries 151 typically extend through the second arrayer block 150 from the upper surface 154 to the lower surface 155 thereof. In order to reduce the volume of the biosample solution in each capillary, the second arrayer capillaries 151 in the second arrayer block 150 are configured to have a smaller diameter than the first arrayer capillaries 142 in the first arrayer block 140. For example, in one embodiment of the present invention, the first arrayer capillaries 142 of the first arrayer block 140 have a diameter of between about one millimeter and about two millimeters while the second arrayer capillaries 151 in the second arrayer block 150 have a diameter of between about 50 microns and about 200 microns. The smaller diameter of the second arrayer capillaries 151 in the second arrayer block 150 reduces the volume per unit length of the solution in the capillary and provides more accurate and easier regulated volumetric control over the flow of the biosample solution from the reservoir 120 to the biochip 200. Thus, it will be understood that, by reducing the dimensions and the spacing of subsequent sets of capillaries, the volume of the individual biosample as well as the area occupied by the corresponding capillary array are accordingly reduced in order to scale the biosamples to the dimensions of the corresponding biochip according to the spirit and scope of the present invention.
In some instances, the first arrayer block 140 may have first arrayer capillaries 142 which are not connected to channels 148 at the lower surface 145 of the first arrayer block 140. In those instances, the second plate 150 also defines a plurality of continuation capillaries 152 corresponding to the unchanneled first arrayer capillaries 142 of the first arrayer block 140 and being configured to have a substantially similar diameter with respect thereto. Accordingly, when the first arrayer block 140 is engaged with the second arrayer block 150, some of the first arrayer capillaries 142 continue through the first arrayer block 140 to the corresponding continuation capillaries 152 in the second arrayer block 150. Where the second arrayer block 150 continues some of the first arrayer capillaries 142 of the first arrayer block 140 with
continuation capillaries 152, the second arrayer block 150 also includes channels 158 defined in the lower surface 155 thereof, with the channels 158 leading to an array of corresponding indentations 156 also defined by the lower surface 155 of the second arrayer block 150. In such instances, the second arrayer block 150 completes the reduction of the area of the original capillary array 142. It is understood, however, that the reduction in the area of the capillary array may be accomplished by various methods consistent with the spirit and scope of the present invention. For example, FIG. 5C illustrates the use of two arrayer blocks 140 and 150 to reduce a larger scale capillary array than was illustrated in FIGS. 3B and 4B. In addition, more than two arrayer blocks may be utilized to further expand the scale of the biosample solution volume and the capillary array corresponding thereto so as to accommodate biochips configured for a large array of biosamples. Thus, it will be further understood that the various methods of reducing the area of the capillary array will be applicable herein with respect to the described embodiments in addition to or in the alternative to the specific configuration described.
Once the capillary array 142 has been reduced to the desired area and the individual biosamples have been reduced to the desired volume, a flow control 160 is operably connected to the lower surface 155 of the last arrayer block 150. The flow control device 160 may include, for example, an array of flow control capillaries 162 corresponding to the previous reduced area capillary array formed by the arrayer blocks. The flow control device 160 is configured to control the flow of the biosamples through the flow control capillaries 162 and may take the form of, for instance, a valve, a pump, or the like. According to one embodiment of the present invention, and as shown in FIG. 6, each flow control capillary 162 may be configured with a micropump 165 capable of providing precise control over the flow of the biosamples through the relatively small flow control capillaries 162. Pumping of a biosample through a capillary 162 may be accomplished using electrostatic pressure generated by a voltage applied along a length of the capillary 162. Generally, a high voltage of 1 to 20 kV, for example, is required to generate the necessary pressure for pumping the biosample in the capillary 162. By using electrostatic pressure to pump the biosamples through the capillaries 162, a precise volume of the biosamples can be pumped through each capillary 162. Note that, in some instances, the voltage may be controlled and/or adjusted so as to form a microvalve capable of preventing and/or
metering the biosample flow through the capillary 162. The movement of molecules by the application of a plurality of electrical fields is further described in U.S. Patent No. 5,126,022 to Soane et al, the contents of which are herein incorporated by reference. However, flow control of the biosamples as mentioned herein may also be accomplished, for instance, with an external pump interfaced with the arrayer apparatus 110 for pumping the biosamples through the capillaries, instead of using an electrostatic pump configured as previously described. Alternatively, for example, an external valve may be engaged with the arrayer apparatus 110, for controlling the flow of the biosamples. Thus, it will be understood that flow control of the biosamples may be achieved in many different manners, in addition to that described, according to spirit and scope of the present invention.
Once the biosamples have been channeled through the flow control device 160, the biosamples flow through a stamper head 180 operably connected to the flow control device 160 and defining an array of stamper capillaries 182 corresponding to the flow control capillaries 162. In some instances, the stamper capillaries 182 may have a reduced diameter, and thus a reduced volume per unit length, with respect to the flow control capillaries 162 for further reducing the biosample volume as discussed herein. Generally, the substrate 200 to which the biosamples are delivered is disposed below the stamper head 180. In order to deliver the biosamples to the substrate 200, the stamper head may be positioned adjacent to the substrate 200 such that the biosamples released from the flow control capillaries 162 flow through the stamper capillaries 182 and then form droplets at the outlets of the stamper capillaries 182. The droplets then contact the substrate 200 and are subsequently transferred thereto by surface tension. In the alternative, the stamper head 180 may be brought into contact with the substrate 200 in order to transfer the biosamples to the substrate 200. A typical sample, for example, may comprise about 100 nanoliters of the original bulk solution. In some instances, the stamper head 180 may also be readily removable and replaceable in order to minimize cross-contamination between subsequent biochips 200. It will be understood, however, that the volume -reducing arrayer apparatus according to embodiments of the present invention may be utilized for other purposes than herein described such as, for example, in aspects of combinatorial chemistry and integrated circuit packaging, within the spirit and scope of the present invention.
Another advantageous aspect of a volume-reducing arrayer apparatus according to the present invention comprises a method of fabricating a volume- reducing arrayer apparatus adapted to deliver a predetermined amount of a liquid solution from a reservoir to a substrate as shown in FIG. 7. First, a first plate defining at least one first plate capillary is operably engaged with a second plate defining at least one second plate capillary so as to form a continuous passage between each first plate capillary and the corresponding second plate capillary (block 210). The first and second plate capillaries are typically arranged in corresponding arrays and extend between an upper surface and a lower surface of the corresponding plate. The plates may be comprised of, for example, a material such as silicon, and the capillaries may be formed therein using standard photolitho graphical techniques commonly employed in the semiconductor industry. According to a photolithographical process, the silicon substrate is coated with a light sensitive photolithographical material, patterned to define shapes corresponding to the capillaries, and the substrate then etched such that the capillaries are formed therein. The second plate capillaries are generally configured to have a diameter smaller than the first plate capillary diameter so as to reduce the volume per unit length of the biosample solution in the capillary. In one embodiment of the present invention, the second plate capillary array extends over an area generally corresponding to the size of the substrate on which the biosamples will be deposited, the area covered by the second plate capillary array being generally smaller than the area covered by the first plate capillary array. A flow control device is then operably engaged with each of the second plate capillaries, wherein the flow control device is configured to control the flow of the solution through each second plate capillary, from each first plate capillary to the substrate (block 220). Still another advantageous aspect of the present invention comprises a method of delivering a biosample solution to a biochip as shown in FIG. 8. First, portions of the biosample solution are delivered from a microtiter plate containing the biosample solution to a plurality of first plate capillaries defined by a first plate, wherein the first plate capillaries are arranged in an array and each of the first plate capillaries has a predetermined diameter (block 230). At least a portion of the biosample solution from each of the first plate capillaries is then delivered to a corresponding second plate capillary in a plurality of second plate capillaries defined by a second plate (block 240). The second plate capillaries are arranged in an array corresponding to
the first plate capillary array. Further, each of the second plate capillaries has a diameter smaller than the first plate capillary diameter such that the smaller diameter of the second plate capillary provides a reduced volume per unit length of the solution therein with respect to the first plate capillary. At least a portion of the biosample solution from each of the second plate capillaries is then delivered to a substrate to form an array of samples on the substrate (block 250).
Thus, embodiments of an arrayer apparatus according to the present invention provide distinct advantages in delivering biosamples onto biochips as compared to current methods such as robotic delivery. More particularly, the arrayer apparatus is capable of delivering the biosamples to the biochips at a higher rate since, for example, no washing step is needed between biochips. Further, the arrayer apparatus may be configured to deliver biosamples to a number of biochips simultaneously, wherein the delivery rate would be on the magnitude of, for instance, biochips per second instead of the typical spots per second rate of current robotic systems. In addition, one load of DNA samples in the microtiter plate may potentially generate a large number of biochips. For example, 5,000 biochips may theoretically be generated from a microtiter plate containing 5 microhters of a DNA solution for each sample. Another advantage of the arrayer apparatus is its relatively low cost since, for instance, the multi-tier microchannel array is relatively easy to manufacture compared to a complex robotic system. The ease of manufacture is facilitated in that many of the components may be manufactured using standard photolithography techniques common to the semiconductor industry.
Embodiments of the arrayer apparatus further provide high precision compared to other techniques. For example, the relative x-y positions of biosamples are maintained at a constant between subsequent biochips since there is no moving of each biochip for the application of the biosamples. Further, the concentrations of the biosamples are typically more uniform because all probes on a chip are deposited simultaneously and the DNA samples are maintained integrally with the arrayer apparatus during the sample delivery process. The arrayer apparatus also allows the amount of the biosample deposited onto the biochip to be more precisely controlled by electronic devices. The configuration of the arrayer apparatus further reduces the risk of cross-contamination between biosamples due to reduced handling thereof and the replaceability of the stamper head. In addition, embodiments of the arrayer
apparatus can be integrated with the sample preparation process before delivery of the biosamples onto the biochip such that potential sources of error between sample preparation and biochip formation are eliminated. For example, a bio-reaction cabin may be attached above the arrayer apparatus for DNA amplification using PCR, more particularly lending itself to the application of strand displacement amplification (SDA).
Thus, the arrayer apparatus according to embodiments of the present invention provides expedient fabrication of biochips in a timely and cost-effective manner. The flow control system, comprising a part of the arrayer apparatus, further provides precise flow and delivery of the biosamples to the biochip while the configuration of the arrayer apparatus minimizes or eliminates various deleterious factors present in current biochip fabrication methods, thereby producing more accurate and repeatable process results than current methods of producing biochips.
Many modifications and other embodiments of the invention will come to mind to one skilled in the art to which this invention pertains having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the invention is not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.